Claudia Perez-Straziota1,2, Ronald N Gaster2,3, Yaron S Rabinowitz2,4,5. 1. Department of Ophthalmology, University of Southern California, Los Angeles, CA. 2. Cornea Eye Institute, Beverly Hills, CA. 3. Department of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, CA. 4. Ophthalmology Research, Cedars-Sinai Medical Center, Los Angeles, CA. 5. Department of Ophthalmology, Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, CA.
Abstract
PURPOSE: To comprehensively review the available published literature for cross-linking in the pediatric population. METHODS: Review of the literature published in English in PubMed. RESULTS: Two hundred ten publications were considered. One hundred fifteen were considered relevant to this review. CONCLUSIONS: Studies of cross-linking in pediatric patients are sparse, with relatively short follow-up times, and mostly on small groups of patients. Treatment with cross-linking halts progression of keratoconus in the pediatric population, and early treatment seems to be cost-effective compared with later penetrating keratoplasty. Long-term effects and regression rates remain unclear, and further studies are needed in this population.
PURPOSE: To comprehensively review the available published literature for cross-linking in the pediatric population. METHODS: Review of the literature published in English in PubMed. RESULTS: Two hundred ten publications were considered. One hundred fifteen were considered relevant to this review. CONCLUSIONS: Studies of cross-linking in pediatricpatients are sparse, with relatively short follow-up times, and mostly on small groups of patients. Treatment with cross-linking halts progression of keratoconus in the pediatric population, and early treatment seems to be cost-effective compared with later penetrating keratoplasty. Long-term effects and regression rates remain unclear, and further studies are needed in this population.
Authors: Paulo Elias Correa Dantas; Milton Ruiz Alves; Maria Cristina Nishiwaki-Dantas Journal: Arq Bras Oftalmol Date: 2005-11-28 Impact factor: 0.872
Authors: Ha Ae Bae; Richard A D Mills; Richard G Lindsay; Tony Phillips; Douglas J Coster; Paul Mitchell; Jie Jin Wang; Jamie E Craig; Kathryn P Burdon Journal: Invest Ophthalmol Vis Sci Date: 2013-07-30 Impact factor: 4.799
Authors: J L Olivares Jiménez; J C Guerrero Jurado; F J Bermudez Rodriguez; D Serrano Laborda Journal: Optom Vis Sci Date: 1997-03 Impact factor: 1.973
Authors: Timothy T McMahon; Linda S Kim; Gerald A Fishman; Edwin M Stone; Xinping C Zhao; Richard W Yee; Jarema Malicki Journal: Invest Ophthalmol Vis Sci Date: 2009-04-30 Impact factor: 4.799
Authors: Julio C Hernandez-Camarena; Enrique O Graue-Hernandez; Denise Loya-García; Raul E Ruiz-Lozano; Jorge E Valdez-García Journal: Clin Ophthalmol Date: 2019-08-30